NIH Reporter #1ZIABC012102-04

Research and Development Services for Enhancing CHyMErA Screening Platform

This opportunity is issued by the Division of Basic Sciences at the National Cancer Institute (NCI) for research and development services to enhance the CHyMErA screening platform. - Government Buyer: - National Cancer Institute (NCI), Division of Basic Sciences - Scope of Work: - Research and development services to improve the CHyMErA screening platform - Focus on CRISPR/Cas genome editing technology - Enhancement of editing efficiency and versatility in human cell lines - Advanced guide RNA design and high-throughput screening - Products/Services Requested: - One lump sum contract for research and development services related to genome editing tools and CRISPR system establishment - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Unique/Notable Requirements: - Emphasis on innovative approaches to genome editing and guide RNA design - Application in human cell lines for high-throughput screening

Description

This procurement involves research services related to CRISPR/Cas technology, genome editing, and high-throughput screening. The project aims to improve guide RNA design, develop genome editing tools, and establish CRISPR systems in human cell lines. The scope includes research and development services to enhance the CHyMErA screening platform's editing efficiency and versatility.

View original listing